Morepen Labs Naresh Sharma resigns as Vice President - Operations (API)
Haryana: Morepen Labs has announced the resignation of Naresh Sharma, Vice President - Operations (API), a Senior Management Personnel.
"We hereby inform that Mr. Naresh Sharma, Vice President – Operations (API), a Senior Management Personnel, has tendered his resignation due to personal reasons, effective today, May 5, 2025," the Company informed in a BSE filing.
Naresh joined Morepen in 2023 and brought with him extensive experience in the pharmaceutical sector. Before his tenure at Morepen, he served as Assistant Vice President – Technology Transfer at PI Industries Ltd. His career also includes roles at Ind-Swift Laboratories Ltd., Ranbaxy/Sun Pharma, Pfizer, and Amrit Banaspati Company Limited.
In a related leadership development, the Medical Dialogues team reported in March that Kushal Suri, another Senior Management Personnel at Morepen, was redesignated as President – International Growth. He previously held the position of Director – API Sales & Marketing.
Read also: Morepen Labs names Kushal Suri as President - International Growth
Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.